Operating Lease, Right-of-Use Asset of IDEXX LABORATORIES INC /DE from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IDEXX LABORATORIES INC /DE quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $128,207,000, a 5.9% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $128,207,000 +$7,154,000 +5.9% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $129,778,000 +$10,252,000 +8.6% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $115,999,000 -$3,887,000 -3.2% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $116,129,000 +$630,000 +0.54% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $121,053,000 +$3,271,000 +2.8% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $119,526,000 +$5,378,000 +4.7% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $119,886,000 +$4,826,000 +4.2% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $115,499,000 -$3,119,000 -2.6% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $117,782,000 +$7,679,000 +7% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $114,148,000 -$1,313,000 -1.1% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $115,060,000 +$7,324,000 +6.8% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $118,618,000 +$13,517,000 +13% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $110,103,000 +$3,141,000 +2.9% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $115,461,000 +$10,738,000 +10% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $107,736,000 +$14,171,000 +15% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $105,101,000 +$13,930,000 +15% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $106,962,000 +$22,227,000 +26% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $104,723,000 +$22,316,000 +27% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $93,565,000 +$14,953,000 +19% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $91,171,000 +$10,564,000 +13% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $84,735,000 +$5,758,000 +7.3% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $82,407,000 +$852,000 +1% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $78,612,000 -$1,982,000 -2.5% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $80,607,000 +$80,607,000 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $78,977,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $81,555,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $80,594,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 14 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.